Government AgencyUS advanced research agency.
Organ-on-Chip
Companies, researchers, investors, standards, events, and funding shaping human-relevant organ-chip systems.
The field
At a glance
Definition
Explore the organ-on-chip landscape, including commercial platforms, scientific leaders, capital, public programs, events, and foundational research.
Field at a glance
- Organ-on-Chip organizations
- 40
- Organ-on-Chip people
- 12
- Organ-on-Chip programs and funding
- 7
Who is working on it, and who is paying for it
Organizations in the field
The labs, companies and funders doing the work, and the groups helping it along.
Research and public institutions 4
Government Agency
Research InstituteNIH center coordinating the Tissue Chip for Drug Screening program.
Government AgencyUS measurement science and standards agency.
Research InstituteHarvard institute where foundational human organ-chip systems were developed.
Funders 21
Grant MakerU.S. health research agency funding ambitious programs, including organ-chip work in space.
Grant MakerUK organization funding and advancing non-animal research methods.
Grant MakerNIH institute encouraging microphysiological-system pilot studies in diabetes research.
Venture Capital
Venture Capital
Venture CapitalInvesting in frontier technology for a healthier planet.
Show all 21 funders
Corporate Venture Capital
Corporate Venture CapitalInvesting in innovative in vitro diagnostic technologies.
Venture Capital
Venture Capital
GlenRock Capital
Venture CapitalEmpowering innovation through strategic investments.
Venture CapitalInvesting in groundbreaking scientific innovations.
Venture CapitalInvesting in disruptive technology companies.
Family OfficeInvesting for a sustainable future.
Venture CapitalInvesting in the future of deep health.
Venture CapitalAdvancing Science for the Benefit of Humanity
Grant MakerSupporting innovation and economic growth in East Netherlands.
Venture Capital
Corporate Venture CapitalCorporate Venture Capital
Venture CapitalInvesting in the future of health and wellness.
Companies 10
StartupDevelops mechanically active organ-on-chip systems, including breathing lung models.
StartupDevelops mechanically stimulated beating organ-on-chip models.
StartupDevelops PhysioMimix single- and multi-organ microphysiological systems.
StartupDevelops Organ-Chip systems and human-relevant tissue models for drug discovery and development.
StartupProvides Human-on-a-Chip systems and contract research for drug safety and efficacy.
StartupDevelops 3D tissue and Akura Flow organ-on-chip platforms for preclinical research.
Show all 10 companies
StartupDevelops the OrganoPlate organ-on-chip platform and human tissue models for drug development.
StartupCombines patient-on-chip experiments with machine learning for clinical prediction.
StartupDevelops HUMIMIC human-on-a-chip and multi-organ-chip systems.
StartupUses microfluidic human tissue systems and robotics to generate predictive biological data.
Associations and field builders 3
CommunityEuropean society connecting researchers, companies, and stakeholders in organ-on-chip technology.
CommunityEuropean industry association representing microphysiological-system providers.
CommunityEmpowering innovation and economic growth in South Holland.
Other organizations 2
OtherU.S. regulator advancing qualification and use of human-relevant drug-development tools.
OtherInnovative solutions across diverse sectors.
Money and ways in
Programs and funding
Programs and fellowships 5
other
ARPA-H initiative using microphysiological systems to study tissue aging in low Earth orbit.
- Type
- Other
other
FDA qualification program for innovative drug-development tools, including organ-chip approaches.
- Type
- Other
other
Completed DARPA program that developed interlinked human microphysiological systems.
- Type
- Other
other
Working group developing organ-on-chip engineering and efficacy standards.
- Type
- Other
other
NIH program developing human tissue chips to improve prediction of drug safety and toxicity.
- Type
- Other
Open funding opportunities 1
Funding opportunity
- Deadline
- Sep 10, 2028
Other funding opportunities 1
Funding opportunity
- Deadline
- Oct 7, 2026
Next door
Related sectors
Sector
Biotechnology, drug discovery, gene therapy, diagnostics, and life sciences R&D.
Sector
Engineered organisms and biological systems for sustainable manufacturing processes
Sector
Technologies optimizing production of biologics, vaccines, and biopharmaceuticals
Sector
Therapeutic approaches modifying cells or genes to treat genetic diseases
Sector
Software-based medical treatments delivering clinical outcomes without drugs
Sector
Platforms accelerating identification and development of new pharmaceutical compounds
Is this page right?How the research works